Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in preterm infants

Cochrane Database of Systematic Reviews

Volumn 2019, Issue 2, 2019, Pages

  Walsh, Verena ^a   Valeska, Jennifer ^a   Brown, Elli ^a   McGuire, William ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE;

ADVERSE OUTCOME; DIET SUPPLEMENTATION; ENTERIC FEEDING; EVIDENCE BASED MEDICINE; GESTATIONAL AGE; HEARING IMPAIRMENT; HOSPITAL DISCHARGE; HUMAN; INTERMETHOD COMPARISON; MORBIDITY; MORTALITY; NERVOUS SYSTEM DEVELOPMENT; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PREMATURITY; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; VISUAL IMPAIRMENT; DEFICIENCY; DEVELOPMENTAL DISORDER; DIETARY SUPPLEMENT; INFANT; INFANT MORTALITY; META ANALYSIS; NEWBORN;

DEVELOPMENTAL DISABILITIES; DIETARY SUPPLEMENTS; ENTERAL NUTRITION; HUMANS; INFANT; INFANT MORTALITY; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; INFANT, PREMATURE; IODINE; PARENTERAL NUTRITION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85062348933     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005253.pub3     Document Type: Review

References (39)

1. Rogahn J, Ryan S, Wells J, Fraser B, Squire C, Wild N, et al., Randomised trial of iodine intake and thyroid status in preterm infants. Archives of Disease in Childhood. Fetal and Neonatal Edition 2000; 83 (2): F86-90. [PUBMED: 10952698] 10127129
2. Williams F, Hume R, Ogston S, Brocklehurst P, Morgan K, Juszczak E, et al., A summary of the iodine supplementation study protocol (I2S2): a UK multicentre randomised controlled trial in preterm infants. Neonatology 2014; 105 (4): 282-9. [DOI: 10.1159/000358247; PUBMED: 24576827] 10127131
3. Williams FL, Ogston S, Hume R, Watson J, Stanbury K, Willatts P, et al., Supplemental iodide for preterm infants and developmental outcomes at 2 years: an RCT. Pediatrics 2017; 139 (5): e20163703. [DOI: 10.1542/peds.2016-3703; PUBMED: 28557747] 10127132
4. Belykh N, Mamenko M, Kovalenko N, Minyaylo N, Plugatarenko N,. Effectiveness of iodine prophylaxis in pregnant, lactating, mothers and infants in mild iodine deficiency region. European Thyroid Journal 2014; 3 Suppl 1: 117-8. 10127134
5. Bouhouch RR, Bouhouch S, Stinca S, Cherkaoui M, Aboussad A, Andersson M, et al., Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal 2013; 27 Suppl 1: lb1-1217.39. 10127136
6. Kurtoǧlu S, Köroǧlu Ş, Baştuǧ O, Daar G, Yikilmaz A, Elmali F,. The comparison of thyroxine versus thyroxine plus oral iodine in the treatment of congenital hypothyroidism due to iodine deficiency. Hormone Research in Paediatrics 2014; 81 (6): 409-15. [DOI: 10.1159/000358878; PUBMED: 24776962] 10127138
7. Mohammed H, Marquis G, Aboud F, Bougma K, Samuel A,. A cluster RCT evaluating the effect of iodized salt on infant development in Amhara region of Ethiopia. FASEB Journal 2015; 29 Suppl 1: LB264. 10127140
8. Wang YL, Ge PF, Cao YQ, Zheng J, Dun W, Li HB, et al., Evaluation of iodine supplementation on improvement of developmental quotient at the critical period of infant brain development. Chinese Journal of Endemiology 2013; 32 (4): 400-3. 10127142
9. Agostoni C, Buonocore G, Carnielli VP, De Curtis M, Darmaun D, Decsi T, et al., Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. Journal of Pediatric Gastroenterology and Nutrition 2010; 50 (1): 85-91. [DOI: 10.1097/MPG.0b013e3181adaee0; PUBMED: 19881390]
10. Aitken J, Williams FL,. A systematic review of thyroid dysfunction in preterm neonates exposed to topical iodine. Archives of Disease in Childhood. Fetal and Neonatal Edition 2014; 99 (1): F21-8. [DOI: 10.1136/archdischild-2013-303799; PUBMED: 24105624]
11. Ares S, Escobar-Morreale HF, Quero J, Duran S, Presas MJ, Herruzo R, et al., Neonatal hypothyroxinemia: effects of iodine intake and premature birth. Journal of Clinical Endocrinology and Metabolism 1997; 82 (6): 1704-12. [DOI: 10.1210/jcem.82.6.4019; PUBMED: 9177368]
12. Belfort MB, Pearce EN, Braverman LE, He X, Brown RS,. Low iodine content in the diets of hospitalized preterm infants. Journal of Clinical Endocrinology and Metabolism 2012; 97 (4): E632-6. [DOI: 10.1210/jc.2011-3369; PUBMED: 22337912]
13. Delahunty C, Falconer S, Hume R, Jackson L, Midgley P, Mirfield M, et al., Levels of neonatal thyroid hormone in preterm infants and neurodevelopmental outcome at 5 1/2 years: millennium cohort study. Journal of Clinical Endocrinology and Metabolism 2010; 95 (11): 4898-908. [DOI: 10.1210/jc.2010-0743; PUBMED: 20719832]
14. Den Ouden AL, Kok JH, Verkerk PH, Brand R, Verloove-Vanhorick SP,. The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants. Pediatric Research 1996; 39: 142-5. [DOI: 10.1203/00006450-199601000-00021 ]
15. Forhead AJ, Fowden AL,. Thyroid hormones in fetal growth and prepartum maturation. Journal of Endocrinology 2014; 221 (3): R87-103. [DOI: 10.1530/JOE-14-0025; PUBMED: 24648121]
16. McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed 15 March 2018. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.
17. Higgins JP, Green S, editor(s),. Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017. Available from training.cochrane.org/handbook.
18. Hollanders JJ, Israels J, van der Pal SM, Verkerk PH, Rotteveel J, Finken MJ,. No association between transient hypothyroxinemia of prematurity and neurodevelopmental outcome in young adulthood. Journal of Clinical Endocrinology and Metabolism 2015; 100 (12): 4648-53. [DOI: 10.1210/jc.2015-3078; PUBMED: 26480285]
19. Hollanders JJ, van der Pal SM, Verkerk PH, Rotteveel J, Finken MJ,. Transient hypothyroxinemia of prematurity and problem behavior in young adulthood. Psychoneuroendocrinology 2016; 72: 40-6. [DOI: 10.1016/j.psyneuen.2016.06.008; PUBMED: 27343725]
20. Ibrahim M, Morreale de Escobar GM, Visser TJ, Duran S, van Toor H, Strachan J, et al., Iodine deficiency associated with parenteral nutrition in extreme preterm infants. Archives of Disease in Childhood. Fetal and Neonatal Edition 2003; 88 (1): F56-7. [PUBMED: PMC1756012]
21. Kieran EA, O'Sullivan A, Miletin J, Twomey AR, Knowles SJ, O'Donnell CP,. 2% chlorhexidine-70% isopropyl alcohol versus 10% povidone-iodine for insertion site cleaning before central line insertion in preterm infants: a randomised trial. Archives of Disease in Childhood. Fetal and Neonatal Edition 2018; 103 (2): F101-6. [DOI: 10.1136/archdischild-2016-312193; PUBMED: 29074717]
22. Koo W, Tice H,. Human milk fortifiers do not meet the current recommendation for nutrients in very low birth weight infants. Journal of Parenteral and Enteral Nutrition 2017; 42 (4): 813-20. [DOI: 10.1177/0148607117713202; PUBMED: 28622483]
23. Liggins GC, Schellenberg JC, Manzai M, Kitterman JA, Lee CC,. Synergism of cortisol and thyrotropin releasing hormone in lung maturation in fetal sheep. Journal of Applied Physiology 1988; 65 (4): 1880-4. [DOI: 10.1152/jappl.1988.65.4.1880; PUBMED: 3141365]
24. Lucas A, Morley R, Fewtrell MS,. Low triiodothyronine concentration in preterm infants and subsequent intelligence quotient (IQ) at 8 year follow up. BMJ 1996; 312 (7039): 1132-3. [PUBMED: 8620130]
25. Meijer WJ, Verloove-Vanhorick SP, Brand R, van den Brande JL,. Transient hypothyroxinaemia associated with developmental delay in very preterm infants. Archives of Disease in Childhood 1992; 67 (7): 944-7. [PUBMED: 1381573]
26. Murphy N, Hume R, van Toor H, Matthews TG, Ogston SA, Wu SY, et al., The hypothalamic-pituitary-thyroid axis in preterm infants; changes in the first 24 hours of postnatal life. Journal of Clinical Endocrinology and Metabolism 2004; 89 (6): 2824-31. [DOI: 10.1210/jc.2003-030317; PUBMED: 15181064]
27. Osborn DA, Hunt RW,. Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD005948.pub2 ]
28. Osborn DA, Hunt RW,. Postnatal thyroid hormones for preterm infants with transient hypothyroxinaemia. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD005945.pub2 ]
29. Reuss ML, Paneth N, Pinto-Martin JA, Lorenz JM, Susser M,. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. New England Journal of Medicine 1996; 334 (13): 821-7. [DOI: 10.1056/NEJM199603283341303; PUBMED: 8596548]
30. Reuss ML, Leviton A, Paneth N, Susser M,. Thyroxine values from newborn screening of 919 infants born before 29 weeks' gestation. American Journal of Public Health 1997; 87 (10): 1693-7. [PUBMED: 9357357]
31. Rooman RP, Du Caju MV, De Beeck LO, Docx M, Van Reempts P, Van Acker KJ,. Low thyroxinaemia occurs in the majority of preterm newborns. European Journal of Pediatrics 1996; 155 (3): 211-5. [PUBMED: 8929730]
32. Schünemann H, Brozek J, Guyatt G, Oxman A, editor(s),. Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.
33. Scratch SE, Hunt RW, Thompson DK, Ahmadzai ZM, Doyle LW, Inder TE, et al., Free thyroxine levels after very preterm birth and neurodevelopmental outcomes at age 7 years. Pediatrics 2014; 133 (4): e955-63. [DOI: 10.1542/peds.2013-2425; PUBMED: 24685955]
34. Smerdely P, Lim A, Boyages SC, Waite K, Wu D, Roberts V, et al., Topical iodine containing antiseptics and neonatal hypothyroidism in very-low-birthweight infants. Lancet 1989; 2 (8664): 661-4. [PUBMED: 2570908]
35. van Wassenaer-Leemhuis A, Ares S, Golombek S, Kok J, Paneth N, Kase J, et al., Thyroid hormone supplementation in preterm infants born before 28 weeks' gestational age and neurodevelopmental outcome at age 36 months. Thyroid 2014; 24 (7): 1162-9. [DOI: 10.1089/thy.2013.0618; PUBMED: 24684245]
36. Velasco I, Bath SC, Rayman MP,. Iodine as essential nutrient during the first 1000 days of life. Nutrients 2018; 10 (3): E290. [DOI: 10.3390/nu10030290; PUBMED: 29494508]
37. Williams FL, Hume R,. Perinatal factors affecting thyroid hormone status in extreme preterm infants. Seminars in perinatology 2008; 32 (6): 398-402. [DOI: 10.1053/j.semperi.2008.09.004; PUBMED: 19007676]
38. Williams F, Hume R,. The measurement, definition, aetiology and clinical consequences of neonatal transient hypothyroxinaemia. Annals of Clinical Biochemistry 2011; 48 (Pt 1): 7-22. [PUBMED: 20930033]
39. Ibrahim M, Sinn J, McGuire W,. Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in preterm infants. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD005253.pub2 ]